Work

Abstract 513: AZD5305, a PARP1 selective inhibitor, exhibits antitumor effects and stimulates immune response in homologous recombination (HR)-deficient gastric cancer cells.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-513

Authors: Sujin Ham, Hae Min Hwang, Youlim Noh, Jiwon Koh, Chaeyoung Lee, Seohyeon Lim, Minyoung Jeong, Yu-Jin Kim, Minyoung Lee, Changhee Park, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im

Institutions: Seoul National University, Seoul National University Hospital

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148762371

Cites:

Cited by:

Related to: